Skip to contentT
TuHURA Biosciences, Inc.
T
HURATuHURA Biosciences, Inc. Q2 2016 · 10-Q
Revenue—
Net Income-$2.65M-$2.65MderivedN/M vs Q2 2015 EPS Diluted$0.24$0.24+700.0% vs Q2 2015 Operating Cash Flowderived-$1,233,419N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Feb 12, 2016 · 43 d after period end